does metabolic syndrome or its components correlate with lower urinary tract symptoms in benign prostatic hyperplasia patients?
نویسندگان
چکیده
conclusions in our study, the evidence is not enough to support the hypothesis of the relevance between ms and luts. wide-ranging, prospective and multicentric studies are needed to research the relevance between ms and luts in bph. patients and methods in this study, 237 patients referred to urology policlinic with bph were retrospectively scanned between april 2009 and april 2013. patients with normal digital rectal examination and the prostate specific antigen (psa) level of ≤ 4 ng/ml were evaluated using the international prostate symptom score (ipss) and all the data of the patients' body, including body mass index (bmi), lipid parameters, preprandial blood glucose, and waist circumference. seventy-four patients (31.3%) with mild ipss (0-7) was group 1; 97 patients (40.9%) with moderate ipss (8 - 19) group 2 and 66 patients (27.8%) with severe ipss (20-35) were defined as group 3. group 4 consisted of 117 healthy controls. three groups and controls were compared about ms and its components. the diagnosis criteria of the society of endocrinology and metabolism of turkey were used in ms diagnosis. also, bmi, lipid parameters, preprandial blood glucose, waist circumference, and blood pressure were used as ms parameters. background metabolic syndrome (ms) has become a global public health and has been suggested to be a risk factor for lower urinary tract symptoms (luts). studies evaluating the association between the rate of the ms and luts often showed controversial results. results the average age of patients in group 1 was 69.8 ± 7.2; in group 2, 69.1 ± 7.4; 68.3 ± 7.1 in group 3 and 70.2 ± 7.2 in the control group. metabolic syndrome was determined at 37 patients (50%) in group 1, 45 patients (46.5%) in group 2, 32 patients (48%) in group 3 and 52 patients (44.4%) in controls and no statistically significant correlation was detected between luts and ms in bph (p = 0.113). in the comparison of the four groups in the point of ms parameters, no significant correlation was detected in the levels of total cholesterol (p = 0.337), fasting glucose (p = 0.291), bmi (p = 0.452), low density lipoprotein (ldl, p = 0.069) and triglyceride (p = 0.307). objectives the purpose of this study was to reveal the relevance of ms and its components on the frequency and severity of the luts that were seen with benign prostate hyperplasia (bph) in turkish men or not.
منابع مشابه
Does Metabolic Syndrome or its Components Correlate With Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia Patients?
BACKGROUND Metabolic Syndrome (MS) has become a global public health and has been suggested to be a risk factor for Lower Urinary Tract Symptoms (LUTS). Studies evaluating the association between the rate of the MS and LUTS often showed controversial results. OBJECTIVES The purpose of this study was to reveal the relevance of MS and its components on the frequency and severity of the LUTS tha...
متن کاملRelationship between Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia and Metabolic Syndrome in Korean Men
PURPOSE To investigate any associations between lower urinary tract symptoms (LUTS)/benign prostate hyperplasia (BPH) and metabolic syndrome (MetS). MATERIALS AND METHODS In all, 1,224 male police officers in their 50s who had participated in health examinations were included. LUTS/BPH was assessed by serum prostate-specific antigen, International Prostate Symptom Score (IPSS), transrectal ul...
متن کاملBenign prostatic hyperplasia and lower urinary tract symptoms: research priorities.
Department of Urology, Sant’Andrea Hospital, University ‘‘La Sapienza,’’ Rome, Italy; Department of Urology, University Medical Centre HamburgEppendorf, Hamburg, Germany; Urology Clinic, Second University of Naples, Naples, Italy; Universitätsspital Basel, Urologische Klinik, Basel, Switzerland; Department of Urology, University Hospital of Lublin, Lublin, Poland; Department of Urology, Vita-Sa...
متن کاملEarly efficacy of silodosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
OBJECTIVES To evaluate the early efficacy of the alpha(1A)-adrenoceptor selective drug, silodosin, for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia. METHODS A total of 68 patients with an International Prostate Symptom Score (IPSS) of >==8 and a Quality of Life (QOL) index of >==2 were included. Changes in the IPSS and QOL index were evaluated befor...
متن کاملThe relationships between metabolic syndrome, erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia.
OBJECTIVE To determine the relationship between erectile dysfunction and metabolic syndrome (MetS) in patients with benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). MATERIAL AND METHODS Seventy-eight patients who were admitted to our outpatient clinic because of BPH-related LUTS over 40 years of age were included in the study. Patients with LUTS and erectile dysfunc...
متن کاملRe: The relationships between metabolic syndrome, erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia.
Available online at www.turkishjournalofurology.com The authors evaluated the relationship between metabolic syndrome (MetS) and lower urinary tract symptoms (LUTS) as well as erectile dysfunction (ED) in patients with BPH. As the effect of metabolic syndrome has been extensively studied on patients’ LUTS, authors also concluded that frequency of MetS increased with respect to the severity of s...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
nephro-urology monthlyجلد ۷، شماره ۳، صفحات ۰-۰
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023